Name: Retatrutide
Brand: Welcome to the lab
Price: 120.00 NZD
Availability: OutOfStock

$120.00

RETATRUTIDE

Retatrutide is a next-generation metabolic compound designed to target three key hormone pathways involved in appetite, metabolism and energy regulation.

Its triple-action approach has made Retatrutide one of the most talked-about compounds in the modern weight-management and metabolic-health space.

BENEFITS

🍽️ Appetite & Hunger Control
Retatrutide targets multiple pathways involved in appetite regulation, helping reduce hunger and making it easier to control food intake and stay on track with nutritional goals.

🔥 Weight Management
Clinical trials have shown substantial reductions in body weight with Retatrutide, making it a major focus of next-generation weight-management research.

😌 Increased Fullness
By influencing appetite and satiety pathways, Retatrutide can help promote a fuller feeling for longer, supporting better portion control and reduced food intake.

⚡ Metabolic Support
Retatrutide works across multiple metabolic pathways involved in glucose regulation and energy balance, supporting a more comprehensive approach to metabolic health.

🔥 Fat-Loss & Body Composition
The significant weight reductions seen in clinical trials have driven major interest in Retatrutide for body-composition and fat-loss goals.

🩸 Glucose Regulation
Retatrutide influences pathways involved in glucose control and insulin signalling, making metabolic regulation a key part of its profile.

💪 Next-Generation Approach
Unlike single- or dual-pathway treatments, Retatrutide activates three pathways simultaneously, combining GLP-1, GIP and glucagon activity into one approach.

WHY RETATRUTIDE?

Retatrutide stands out because of its triple-action approach.

By targeting GLP-1, GIP and glucagon pathways together, Retatrutide is designed around three important areas of weight management:

Appetite → Metabolism → Energy Balance

This combination has produced significant results in clinical trials and has positioned Retatrutide as one of the most anticipated compounds in the next generation of weight-management treatments.